+86-51783706900
globalbusiness@hanbon.com.cn

en

Jiangsu Hanbon Science&Technology Co., Ltd.
Jiangsu Hanbon Science&Technology Co., Ltd.
Overall Chromatography Technical Advantages From Laboratory Scale To Industrial Scale
Hanbon Science and Technology Co., Ltd. continuously develops new products, optimizes product lines, keeps pace with the development trend of biopharmaceuticals, and provides R&D and production equipment for the synthesis, purification and delivery of emerging small nucleic acid drugs, mRNA vaccines, and cell therapy drugs.
Bio-Oligo Laboratory Nucleic Acid Synthesis Instrument Bio-Oligo Pro 400 Nucleic Acid Synthesizer Bio Oligo Pro Series Production Grade Nucleic Acids Oligonucleotide Synthesis Column
Oligo Synthesizer From lab scale to commercial production, automatic oligonucleotide synthesizers are available from Bio Oligo 10 to Bio Oligo Pro 3000. Meeting the needs from small scale synthesis、process development to mid-phase clinical trials and commercial production.
Bio-Oligo Laboratory Nucleic Acid Synthesis Instrument Bio-Oligo Pro 400 Nucleic Acid Synthesizer Bio Oligo Pro Series Production Grade Nucleic Acids Oligonucleotide Synthesis Column
Analytical Supercritical Fluid Chromatography SFC-Dynamic Axial Compression Column CO₂ Booster Station
Supercritical Fluid Chromatography Supercritical fluid chromatography(SFC) can maximize separation efficiency, reduce solvent consumption, reduce costs, and be environmentally friendly.
Analytical Supercritical Fluid Chromatography SFC-Dynamic Axial Compression Column CO₂ Booster Station
Preparative Liquid Chromatography System Chromatographic Column
Preparative HPLC High accuracy, high stability, ensuring process reproducibility, providing complete GMP and FDA verification documents and services.
Preparative Liquid Chromatography System Chromatographic Column
Chromatography Column Chromatography System Buffer Dilution/ Conditioning System Filtration System Single-use System
Biopharm Purification Equipment Chromatography systems and Filtration systems are necessary for the separation and purification of antibodies, vaccines, recombinant protein drugs, blood products, etc.
Chromatography Column Chromatography System Buffer Dilution/ Conditioning System Filtration System Single-use System
Total Solutions For Drug Purification
Our products and technologies are widely used in the research, development and production of a broad range of pharmaceuticals, including but not limited to peptides, insulins, monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), vaccines, omega-3 fatty acids, contrast media, antibiotics, and natural products.
Biopharmaceutical Purification

Biopharmaceutical Purification
Peptide Purification

Peptide Purification
Small Molecule Purification

Small Molecule Purification
About Hanbon

Founded in 1998, Hanbon Sci.&Tech. Co.,Ltd. is a national ‘small giant’ enterprise specialising in liquid chromatography products and a national high-tech enterprise. The enterprise has been approved to build several provincial R&D platforms, such as Jiangsu Postdoctoral Innovation Base and Jiangsu Industrial Chromatography Technology Innovation Centre, and owns nearly more than 560 intellectual property achievements.

Know More About Hanbon

60 +

​7 Full-time Ph.D. and 50+ with master's degree

650 +

Current Employees

560 +

Intellectual property achievements
2 Enterprise Workstations, 3 Research Centers.

2 Enterprise Workstations, 3 Research Centers.

The New Workshop Covers An Area Of 100,000 Square Meters

The New Workshop Covers An Area Of 100,000 Square Meters

Exported To 20+ Countries, Including Britain

Exported To 20+ Countries, Including Britain

Certifications For Hanbon
GET IN TOUCH WITH HANBON
Whether you have a question about Hanbon Science and Technology Co., Ltd.’s biopharmaceutical equipment or anything else, we're here to help and ready to answer your questions.
E-mail
globalbusiness@hanbon.com.cn
Call Us
+86-51783706900
Address
No.1-9 Jixian Road, Economic Development Zone, Huaian City, Jiangsu Province, China.
Contact Us
Updates From Hanbon
19 Dec
2025
Exploring Influenza Vaccine Production: The Path to Ensuring Purity and Safety
The latest data released by the Chinese Center for Disease Control and Prevention shows that influenza viruses are the main detected pathogens recently. The overall influenza epidemic is at a high pre...
View More
15 Dec
2025
A Purification Tool Bridging the Explosion-Proof Gap
In industrial fields such as chemical synthesis, pharmaceutical production, and natural product extraction, many production workshops harbor an "invisible risk"—explosive environments. Vola...
View More
12 Dec
2025
The Birth of a New Drug King! Unveiling the Purification Battle Behind the Multi-Billion-Dollar Tirzepatide
According to Eli Lilly and Company's 2025 Q3 financial report, its metabolic therapy drug tirzepatide (including the anti-diabetic version Mounjaro and the weight-loss version Zepbound) achieved q...
View More

Copyright ©  Jiangsu Hanbon Science&Technology Co., Ltd.  All Rights Reserved.

Sitemap  |  Privacy Policy